SERA Shariah Compliance

Screening Methodology: AAOIFI

lock image
UNLOCK FOR FREE

Last Updated: March 23, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Sera Prognostics Inc (SERA)

Based on 9 analysts giving stock ratings to Sera Prognostics Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
45
Buy
44
Hold
11
Sell
0
Strong Sell
0
Sera Prognostics Inc

Sera Prognostics Inc. Stock Analysis SERA

United States Health Care Micro Cap Report:
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. The company is headquartered in Salt Lake City, Utah and currently employs 63 full-time employees. The company went IPO on 2021-07-15. The company has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.
Read More

Sera Prognostics Inc (SERA) Chart

Key Statistics of Sera Prognostics Inc (SERA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.83$2.03

Today's Open

$1.86

Volume

40.08K

P/E Ratio (TTM)

-

52 Week Range

$1.37$4.09

Market Cap

106.52M

Avg. Volume

96.04K

Dividend Yield

-

Financial Metrics & Statements of Sera Prognostics Inc (SERA)

Super Investors Invested in Sera Prognostics Inc (SERA)

Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.

FAQ's for Sera Prognostics Inc (SERA)

  • According to Musaffa’s Shariah screening methodology, Sera Prognostics Inc (SERA) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.